Walleye Trading LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$21.2 - $31.03 $38,414 - $56,226	1,812 New	1,812 $55,000
Q2 2022 Aug 08, 2022	SELL	$27.79 - $50.61 $48,715 - $88,719	-1,753 Reduced 31.63%	3,790 $133,000
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $118,661 - $209,560	2,995 Added 117.54%	5,543 $255,000
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $7,203 - $10,231	124 Added 5.12%	2,548 $169,000
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $100,307 - $147,918	1,635 Added 207.22%	2,424 $161,000
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $12,706 - $39,008	618 Added 361.4%	789 $23,000
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $415,796 - $1.08 Million	-14,776 Reduced 98.86%	171 $11,000
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $209,258 - $303,424	14,947 New	14,947 $287,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.